WEDNESDAY, July 24, 2024 (HealthDay News) -- Just two shots a year of an HIV treatment provided complete protection against infections in highly at-risk women, researchers reported Wednesday. In ...

At the beginning of last summer, a trial conducted on 5,000 adolescents and young women in the most HIV-affected areas of Africa showed that a drug injected only twice a year was able to prevent a ...

Two shots a year of a drug currently used to treat HIV infections were dramatically effective at preventing infections in a study among young women and adolescent girls in Africa.

While a vaccine to prevent HIV still is needed, some experts say the new shot could be the next best thing.

While a vaccine to prevent HIV still is needed, some experts say this new shot could be the next best thing.

The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and possibly eradicate the disease.

Groundbreaking twice-a-year HIV drug that could stop transmission approved It's unclear how many people in the US and abroad will get access to the powerful new HIV prevention medication ...

While a vaccine to prevent HIV still is needed, some experts say the shot made by Gilead Sciences — a drug called lenacapavir — could be the next best thing.

The Food and Drug Administration approved Wednesday a powerful new drug that provides nearly complete protection against HIV infection with just a single administration every six months. The ...

The FDA on Wednesday approved a highly effective long-acting shot for HIV prevention that is administered just twice per year, greatly extending the time people can go between doses of a ...

Coco Gauff claimed her second career grand slam singles title on Saturday, coming from behind to defeat world No. 1 Aryna Sabalenka 6-7 (5), 6-2, 6-4 in a thrilling French Open women’s final.

Since reporting last June that just two annual shots of lenacapavir prevented all HIV infections in a study of women and girls, shares have surged 73%.